Baidu
map

J CLIN ONCOL:吸烟影响胰腺癌患者生存

2017-03-31 MedSci MedSci原创

胰腺癌诊断后大部分患者存活期不到12个月。除了疾病分期外,其他的预后因素研究较少。吸烟会增加胰腺癌的发病风险,与约20%的胰腺癌进展有关。但是很少有研究关注吸烟与胰腺癌患者生存之间的关系。

胰腺癌诊断后大部分患者存活期不到12个月。除了疾病分期外,其他的预后因素研究较少。吸烟会增加胰腺癌的发病风险,与约20%的胰腺癌进展有关。但是很少有研究关注吸烟与胰腺癌患者生存之间的关系。

J CLIN ONCOL近期报道了一篇文章研究吸烟对胰腺癌患者生存的影响。作者分析了1986-2013年之间确诊的胰腺癌患者吸烟情况。在485例患者中评估诊断前循环可替宁(与香烟暴露成比例的尼古丁代谢产物)水平对生存的影响。根据诊断前可替宁水平将患者分为不吸烟者(<3.1ng/ml),轻度吸烟者(3.1-20.9ng/ml)以及重度吸烟者(≥21.0nk/ml)。使用Cox比例风险模型评估死亡风险比(HRs)。研究结果表明与不吸烟患者相比,吸烟患者的死亡风险比为1.37(P=0.003)。随着吸烟量增加患者生存下降。戒烟患者与不吸烟患者生存情况相似。与不吸烟患者相比,根据诊断前循环可替宁水平判定为重度吸烟患者的死亡风险比为1.76。在确诊前5年内评估循环可替宁水平的患者中,重度吸烟患者的死亡风险是不吸烟患者的2.47倍。

作者最后得出结论,吸烟与胰腺癌患者生存下降有关。

原始出处:
Chen Yuan,Vicente Morales-Oyarvide,et al.Cigarette Smoking and Pancreatic Cancer Survival.J CLIN ONCOL.March 30 2017 doi:10.1200/JCO.2016.71.2026

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1864868, encodeId=8122186486895, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Aug 28 07:37:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932561, encodeId=5f7a193256128, content=<a href='/topic/show?id=5cd95305803' target=_blank style='color:#2F92EE;'>#患者生存#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53058, encryptionId=5cd95305803, topicName=患者生存)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sat Aug 26 19:37:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184911, encodeId=18b21849110d, content=禁烟是必要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Apr 03 17:13:13 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184359, encodeId=521f18435922, content=烟厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/03/49a8b8e59b1110232178c436948997ae.jpg, createdBy=90151681386, createdName=哈夫, createdTime=Sat Apr 01 20:10:46 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184041, encodeId=e5641840416a, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 31 15:22:42 CST 2017, time=2017-03-31, status=1, ipAttribution=)]
    2017-08-28 minlingfeng
  2. [GetPortalCommentsPageByObjectIdResponse(id=1864868, encodeId=8122186486895, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Aug 28 07:37:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932561, encodeId=5f7a193256128, content=<a href='/topic/show?id=5cd95305803' target=_blank style='color:#2F92EE;'>#患者生存#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53058, encryptionId=5cd95305803, topicName=患者生存)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sat Aug 26 19:37:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184911, encodeId=18b21849110d, content=禁烟是必要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Apr 03 17:13:13 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184359, encodeId=521f18435922, content=烟厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/03/49a8b8e59b1110232178c436948997ae.jpg, createdBy=90151681386, createdName=哈夫, createdTime=Sat Apr 01 20:10:46 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184041, encodeId=e5641840416a, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 31 15:22:42 CST 2017, time=2017-03-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1864868, encodeId=8122186486895, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Aug 28 07:37:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932561, encodeId=5f7a193256128, content=<a href='/topic/show?id=5cd95305803' target=_blank style='color:#2F92EE;'>#患者生存#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53058, encryptionId=5cd95305803, topicName=患者生存)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sat Aug 26 19:37:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184911, encodeId=18b21849110d, content=禁烟是必要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Apr 03 17:13:13 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184359, encodeId=521f18435922, content=烟厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/03/49a8b8e59b1110232178c436948997ae.jpg, createdBy=90151681386, createdName=哈夫, createdTime=Sat Apr 01 20:10:46 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184041, encodeId=e5641840416a, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 31 15:22:42 CST 2017, time=2017-03-31, status=1, ipAttribution=)]
    2017-04-03 大爰

    禁烟是必要的!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1864868, encodeId=8122186486895, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Aug 28 07:37:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932561, encodeId=5f7a193256128, content=<a href='/topic/show?id=5cd95305803' target=_blank style='color:#2F92EE;'>#患者生存#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53058, encryptionId=5cd95305803, topicName=患者生存)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sat Aug 26 19:37:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184911, encodeId=18b21849110d, content=禁烟是必要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Apr 03 17:13:13 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184359, encodeId=521f18435922, content=烟厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/03/49a8b8e59b1110232178c436948997ae.jpg, createdBy=90151681386, createdName=哈夫, createdTime=Sat Apr 01 20:10:46 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184041, encodeId=e5641840416a, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 31 15:22:42 CST 2017, time=2017-03-31, status=1, ipAttribution=)]
    2017-04-01 哈夫

    烟厂

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1864868, encodeId=8122186486895, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Mon Aug 28 07:37:00 CST 2017, time=2017-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1932561, encodeId=5f7a193256128, content=<a href='/topic/show?id=5cd95305803' target=_blank style='color:#2F92EE;'>#患者生存#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53058, encryptionId=5cd95305803, topicName=患者生存)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=47c5349, createdName=tastas, createdTime=Sat Aug 26 19:37:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184911, encodeId=18b21849110d, content=禁烟是必要的!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Apr 03 17:13:13 CST 2017, time=2017-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184359, encodeId=521f18435922, content=烟厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/03/49a8b8e59b1110232178c436948997ae.jpg, createdBy=90151681386, createdName=哈夫, createdTime=Sat Apr 01 20:10:46 CST 2017, time=2017-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=184041, encodeId=e5641840416a, content=很好的学习资料,谢谢了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161026/IMG58107C0F82E499574.jpg, createdBy=00e81970035, createdName=1e15b6fem30(暂无匿称), createdTime=Fri Mar 31 15:22:42 CST 2017, time=2017-03-31, status=1, ipAttribution=)]
    2017-03-31 1e15b6fem30(暂无匿称)

    很好的学习资料,谢谢了。

    0

相关资讯

Ann Surg:虞先浚教授团队发表“CA19-9假阴性”胰腺癌人群鉴定研究成果

近日,复旦大学附属肿瘤医院胰腺外科虞先浚教授团队关于“CA19-9假阴性”胰腺癌人群鉴定的相关研究在《外科学年鉴》(Annuals of Surgery)上发表。糖类抗原19-9(CA19-9)是目前公认的在胰腺癌的筛查、诊断、预后判断以及治疗指导中最为重要的肿瘤标志物。这一抗原最早被单克隆抗体116NS19-9识别,并在临床中广泛使用,因此命名为CA19-9。CA19-9水平的变化可以提示胰腺癌

《自然》子刊:脑洞大开!小小改进让胰腺癌早期诊断准确度几近翻倍

胰腺癌是一种临床表现隐匿、发展迅速和预后极差的消化道恶性肿瘤。胰腺癌在所有主要癌症中具有最低的存活率,其中一个最主要原因就是缺乏在其早期可治疗阶段中检测该疾病的诊断工具。

Shire胰腺癌药物Onivyde惨遭英国NICE拒绝!

英国制药公司Shire的胰腺癌药物Onivyde近日在英国监管方面遭受挫折。英国NICE发布最终指南,拒绝将Onivyde用于英国国家服务系统(NHS)用于胰腺癌患者的治疗。具体而言,NICE拒绝批准Onivyde联合5-氟尿嘧啶(5-FU)及亚叶酸(LV)用于吉西他滨方案治疗后病情进展的转移性胰腺癌患者。在美国和欧盟,Oniv

Nature:脑洞大开!小小改进让胰腺癌早期诊断准确度几近翻倍

胰腺癌是一种临床表现隐匿、发展迅速和预后极差的消化道恶性肿瘤。胰腺癌在所有主要癌症中具有最低的存活率,其中一个最主要原因就是缺乏在其早期可治疗阶段中检测该疾病的诊断工具。近日,由贝斯以色列女执事医疗中心(BIDMC)高级医学成像和光学中心主任Lev T. Perelman博士领导的一个研究小组,开发出一种意义重大的新工具,利用散射分光镜技术和诊断算法,能够快速区分出胰腺良性囊肿、癌性和癌前期囊肿,

与胰腺癌相关的8种因素,糖尿病是其中之一

胰腺癌是指胰外分泌腺的恶性肿瘤,表现为腹痛、食欲不振、消瘦和黄疸,恶性程度高,预后差。近年来,胰腺癌的发病率明显上升,发病年龄以 45-65 岁多见,男女之比为 1.58:1。但胰腺癌的病因至今未明,国内外研究发现可能与以下8种因素有关。

Lancet Gastroen Heptaol:紫杉醇+氟尿嘧啶:有望成为转移性胰腺癌的一线治疗

紫杉醇联合吉西他滨是转移性胰腺癌的标准治疗方案,然而回顾性资料显示 50%~60% 的患者对吉西他滨单药治疗无效,因此该方案并非最佳治疗方案。

Baidu
map
Baidu
map
Baidu
map